Buyer not eager because they are pushing the price too high, and they want to aquire more.Give it a few more days to pan out.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025